Literature DB >> 8044821

Relevance of the T cell receptor for immunotherapy of cancer.

E Weidmann1, M Trucco, T L Whiteside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8044821     DOI： 10.1007/bf01517174

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  175 in total

1.  Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

Authors:  D Berd; H C Maguire; P McCue; M J Mastrangelo
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

Review 2.  Superantigens.

Authors:  T Chatila; R S Geha
Journal:  Curr Opin Immunol       Date:  1992-02       Impact factor: 7.486

3.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 4.  The T cell receptor/CD3 complex: a dynamic protein ensemble.

Authors:  H Clevers; B Alarcon; T Wileman; C Terhorst
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.

Authors:  F Spertini; H Spits; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

Authors:  Z Ram; K W Culver; S Walbridge; R M Blaese; E H Oldfield
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

7.  In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

Authors:  P J Spiess; J C Yang; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

8.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

9.  A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.

Authors:  N P Restifo; P J Spiess; S E Karp; J J Mulé; S A Rosenberg
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  1 in total

1.  In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.

Authors:  Y Sun; P Möller; C Berking; E M Schlüpen; M Volkenandt; D Schadendorf
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.